Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 31% ± 14% | |
conventional dendritic cell | 3 studies | 20% ± 2% | |
ciliated cell | 3 studies | 22% ± 4% | |
dendritic cell | 3 studies | 24% ± 6% |
Insufficient scRNA-seq data for expression of ZFPL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1834.41 | 180 / 180 | 100% | 6.79 | 430 / 430 |
brain | 100% | 1272.19 | 2637 / 2642 | 100% | 4.81 | 705 / 705 |
esophagus | 100% | 1651.34 | 1445 / 1445 | 99% | 3.77 | 182 / 183 |
intestine | 100% | 1794.59 | 966 / 966 | 99% | 4.44 | 524 / 527 |
prostate | 100% | 2061.76 | 245 / 245 | 99% | 6.70 | 499 / 502 |
uterus | 100% | 1959.72 | 170 / 170 | 99% | 3.76 | 456 / 459 |
thymus | 100% | 1799.04 | 653 / 653 | 99% | 4.01 | 601 / 605 |
stomach | 100% | 1447.80 | 359 / 359 | 99% | 4.31 | 284 / 286 |
skin | 100% | 1878.38 | 1809 / 1809 | 99% | 3.76 | 466 / 472 |
lung | 100% | 1409.99 | 576 / 578 | 98% | 3.51 | 1137 / 1155 |
breast | 100% | 1873.03 | 459 / 459 | 98% | 3.80 | 1093 / 1118 |
bladder | 100% | 1882.33 | 21 / 21 | 98% | 4.17 | 492 / 504 |
pancreas | 100% | 1107.64 | 328 / 328 | 97% | 3.30 | 173 / 178 |
kidney | 100% | 1458.94 | 89 / 89 | 97% | 2.77 | 870 / 901 |
liver | 100% | 1066.30 | 226 / 226 | 96% | 2.70 | 389 / 406 |
adrenal gland | 100% | 1768.32 | 258 / 258 | 94% | 3.17 | 217 / 230 |
adipose | 100% | 1697.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1997.32 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 5.51 | 80 / 80 |
spleen | 100% | 1708.60 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 3.44 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.70 | 1 / 1 |
muscle | 100% | 1221.66 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1103.97 | 856 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 1030.60 | 903 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 2.98 | 28 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016020 | Cellular component | membrane |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | ZFPL1 |
Protein name | Zinc finger protein-like 1 Zinc finger protein-like 1 (Zinc finger protein MCG4) Zinc finger protein like 1 |
Synonyms | |
Description | FUNCTION: Required for cis-Golgi integrity and efficient ER to Golgi transport. Involved in the maintenance of the integrity of the cis-Golgi, possibly via its interaction with GOLGA2/GM130. . FUNCTION: Required for cis-Golgi integrity and efficient ER to Golgi transport. . FUNCTION: Required for cis-Golgi integrity and efficient ER to Golgi transport. . FUNCTION: Required for cis-Golgi integrity and efficient ER to Golgi transport. . FUNCTION: Required for cis-Golgi integrity and efficient ER to Golgi transport. . FUNCTION: Required for cis-Golgi integrity and efficient ER to Golgi transport. . FUNCTION: Required for cis-Golgi integrity and efficient ER to Golgi transport. . |
Accessions | ENST00000526334.5 ENST00000294258.8 A0A0G2JKQ6 ENST00000453524.6 E9PJ47 ENST00000530488.1 ENST00000532200.1 E9PQ47 ENST00000526945.5 ENST00000530744.5 H0YCU8 O95159 ENST00000525509.1 ENST00000531761.5 E9PMQ3 E9PQA5 E9PNY1 ENST00000526791.1 E9PJX1 |